Published in Health Business Week, May 27th, 2005
Net revenues include favorable foreign currency effects of approximately 2%, compared to the prior year quarter. Net income was $56 million, compared to $46 million for the prior year quarter. Earnings per share (EPS) for the quarter were $0.28, compared to $0.22 for the prior year quarter.
EPS for the quarter on a non-GAAP basis were $0.28, compared to $0.21 for the prior year quarter, excluding the specified items described below. The net effect of foreign currency on EPS...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.